Report Summary
Eternity Insights has published a new study on Global Glucose-Dependent Insulinotropic Receptor Market focusing on key segments as by Type (17-i,ARRY-981,AS-1669058,DS-8500,GSK-2041706,HD-0471042), by Application (Type 2 Diabetes, Obesity, Chronic Obstructive Pulmonary Disease (COPD), Dyslipidemia), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Glucose-Dependent Insulinotropic Receptor Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Glucose-Dependent Insulinotropic Receptor Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Glucose-Dependent Insulinotropic Receptor Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Glucose-Dependent Insulinotropic Receptor Market Segmentation:
Glucose-Dependent Insulinotropic Receptor Market, By Type
- 17-i
- ARRY-981
- AS-1669058
- DS-8500
- GSK-2041706
- HD-0471042
Glucose-Dependent Insulinotropic Receptor Market, By Application
- Type 2 Diabetes
- Obesity
- Chronic Obstructive Pulmonary Disease (COPD)
- Dyslipidemia
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Glucose-Dependent Insulinotropic Receptor market in terms of demand generation. The Glucose-Dependent Insulinotropic Receptor market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Glucose-Dependent Insulinotropic Receptor market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Glucose-Dependent Insulinotropic Receptor Market Taxonomy:
To learn more about this report
Global Glucose-Dependent Insulinotropic Receptor Market Competitive Landscape
The global Glucose-Dependent Insulinotropic Receptor market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Hyundai Pharmaceutical Co.
- Ltd.
- LG Life Science LTD.
- Novartis AG
- Astellas Pharma Inc.
- Neurocrine Biosciences
- Inc.
- Rhizen Pharmaceuticals S.A.
- Yuhan Corporation
- Merck & Co.
- Inc.
- GlaxoSmithKline Plc
- CymaBay Therapeutics
- Inc.
- F. Hoffmann-La Roche Ltd.
- Amgen Inc.
- Daiichi Sankyo Company
- Limited
- Takeda Pharmaceutical Company Limited
- Sanwa Kagaku Kenkyusho Co.
- Ltd.
- Array BioPharma Inc.
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
17-i,ARRY-981,AS-1669058,DS-8500,GSK-2041706,HD-0471042 |
| By Application Outlook |
Type 2 Diabetes, Obesity, Chronic Obstructive Pulmonary Disease (COPD), Dyslipidemia |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Hyundai Pharmaceutical Co., Ltd.,LG Life Science LTD.,Novartis AG,Astellas Pharma Inc.,Neurocrine Biosciences, Inc.,Rhizen Pharmaceuticals S.A.,Yuhan Corporation,Merck & Co., Inc.,GlaxoSmithKline Plc,CymaBay Therapeutics, Inc.,F. Hoffmann-La Roche Ltd.,Amgen Inc.,Daiichi Sankyo Company, Limited,Takeda Pharmaceutical Company Limited,Sanwa Kagaku Kenkyusho Co., Ltd.,Array BioPharma Inc. |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Global Glucose-Dependent Insulinotropic Receptor Industry Market Research Report
1 Glucose-Dependent Insulinotropic Receptor Introduction and Market Overview
1.1 Objectives of the Study
1.2 Definition of Glucose-Dependent Insulinotropic Receptor
1.3 Glucose-Dependent Insulinotropic Receptor Market Scope and Market Size Estimation
1.3.1 Market Concentration Ratio and Market Maturity Analysis
1.3.2 Global Glucose-Dependent Insulinotropic Receptor Value ($) and Growth Rate from 2014-2026
1.4 Market Segmentation
1.4.1 Types of Glucose-Dependent Insulinotropic Receptor
1.4.2 Applications of Glucose-Dependent Insulinotropic Receptor
1.4.3 Research Regions
1.4.3.1 North America Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.2 Europe Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.3 China Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.4 Japan Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.5 Middle East & Africa Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.6 India Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.4.3.7 South America Glucose-Dependent Insulinotropic Receptor Production Value ($) and Growth Rate (2014-2019)
1.5 Market Dynamics
1.5.1 Drivers
1.5.1.1 Emerging Countries of Glucose-Dependent Insulinotropic Receptor
1.5.1.2 Growing Market of Glucose-Dependent Insulinotropic Receptor
1.5.2 Limitations
1.5.3 Opportunities
1.6 Industry News and Policies by Regions
1.6.1 Industry News
1.6.2 Industry Policies
2 Industry Chain Analysis
2.1 Upstream Raw Material Suppliers of Glucose-Dependent Insulinotropic Receptor Analysis
2.2 Major Players of Glucose-Dependent Insulinotropic Receptor
2.2.1 Major Players Manufacturing Base and Market Share of Glucose-Dependent Insulinotropic Receptor in 2018
2.2.2 Major Players Product Types in 2018
2.3 Glucose-Dependent Insulinotropic Receptor Manufacturing Cost Structure Analysis
2.3.1 Production Process Analysis
2.3.2 Manufacturing Cost Structure of Glucose-Dependent Insulinotropic Receptor
2.3.3 Raw Material Cost of Glucose-Dependent Insulinotropic Receptor
2.3.4 Labor Cost of Glucose-Dependent Insulinotropic Receptor
2.4 Market Channel Analysis of Glucose-Dependent Insulinotropic Receptor
2.5 Major Downstream Buyers of Glucose-Dependent Insulinotropic Receptor Analysis
3 Global Glucose-Dependent Insulinotropic Receptor Market, by Type
3.1 Global Glucose-Dependent Insulinotropic Receptor Value ($) and Market Share by Type (2014-2019)
3.2 Global Glucose-Dependent Insulinotropic Receptor Production and Market Share by Type (2014-2019)
3.3 Global Glucose-Dependent Insulinotropic Receptor Value ($) and Growth Rate by Type (2014-2019)
3.4 Global Glucose-Dependent Insulinotropic Receptor Price Analysis by Type (2014-2019)
4 Glucose-Dependent Insulinotropic Receptor Market, by Application
4.1 Global Glucose-Dependent Insulinotropic Receptor Consumption and Market Share by Application (2014-2019)
4.2 Downstream Buyers by Application
4.3 Global Glucose-Dependent Insulinotropic Receptor Consumption and Growth Rate by Application (2014-2019)
5 Global Glucose-Dependent Insulinotropic Receptor Production, Value ($) by Region (2014-2019)
5.1 Global Glucose-Dependent Insulinotropic Receptor Value ($) and Market Share by Region (2014-2019)
5.2 Global Glucose-Dependent Insulinotropic Receptor Production and Market Share by Region (2014-2019)
5.3 Global Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.4 North America Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.5 Europe Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.6 China Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.7 Japan Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.8 Middle East & Africa Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.9 India Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
5.10 South America Glucose-Dependent Insulinotropic Receptor Production, Value ($), Price and Gross Margin (2014-2019)
6 Global Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import by Regions (2014-2019)
6.1 Global Glucose-Dependent Insulinotropic Receptor Consumption by Regions (2014-2019)
6.2 North America Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.3 Europe Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.4 China Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.5 Japan Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.6 Middle East & Africa Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.7 India Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
6.8 South America Glucose-Dependent Insulinotropic Receptor Production, Consumption, Export, Import (2014-2019)
7 Global Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis by Regions
7.1 North America Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.2 Europe Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.3 China Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.4 Japan Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.5 Middle East & Africa Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.6 India Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
7.7 South America Glucose-Dependent Insulinotropic Receptor Market Status and SWOT Analysis
8 Competitive Landscape
8.1 Competitive Profile
8.2 Hyundai Pharmaceutical Co., Ltd.
8.2.1 Company Profiles
8.2.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.2.3 Hyundai Pharmaceutical Co., Ltd. Production, Value ($), Price, Gross Margin 2014-2019
8.2.4 Hyundai Pharmaceutical Co., Ltd. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.3 LG Life Science LTD.
8.3.1 Company Profiles
8.3.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.3.3 LG Life Science LTD. Production, Value ($), Price, Gross Margin 2014-2019
8.3.4 LG Life Science LTD. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.4 Novartis AG
8.4.1 Company Profiles
8.4.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.4.3 Novartis AG Production, Value ($), Price, Gross Margin 2014-2019
8.4.4 Novartis AG Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.5 Astellas Pharma Inc.
8.5.1 Company Profiles
8.5.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.5.3 Astellas Pharma Inc. Production, Value ($), Price, Gross Margin 2014-2019
8.5.4 Astellas Pharma Inc. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.6 Neurocrine Biosciences, Inc.
8.6.1 Company Profiles
8.6.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.6.3 Neurocrine Biosciences, Inc. Production, Value ($), Price, Gross Margin 2014-2019
8.6.4 Neurocrine Biosciences, Inc. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.7 Rhizen Pharmaceuticals S.A.
8.7.1 Company Profiles
8.7.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.7.3 Rhizen Pharmaceuticals S.A. Production, Value ($), Price, Gross Margin 2014-2019
8.7.4 Rhizen Pharmaceuticals S.A. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.8 Yuhan Corporation
8.8.1 Company Profiles
8.8.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.8.3 Yuhan Corporation Production, Value ($), Price, Gross Margin 2014-2019
8.8.4 Yuhan Corporation Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.9 Merck & Co., Inc.
8.9.1 Company Profiles
8.9.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.9.3 Merck & Co., Inc. Production, Value ($), Price, Gross Margin 2014-2019
8.9.4 Merck & Co., Inc. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.10 GlaxoSmithKline Plc
8.10.1 Company Profiles
8.10.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.10.3 GlaxoSmithKline Plc Production, Value ($), Price, Gross Margin 2014-2019
8.10.4 GlaxoSmithKline Plc Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.11 CymaBay Therapeutics, Inc.
8.11.1 Company Profiles
8.11.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.11.3 CymaBay Therapeutics, Inc. Production, Value ($), Price, Gross Margin 2014-2019
8.11.4 CymaBay Therapeutics, Inc. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.12 F. Hoffmann-La Roche Ltd.
8.12.1 Company Profiles
8.12.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.12.3 F. Hoffmann-La Roche Ltd. Production, Value ($), Price, Gross Margin 2014-2019
8.12.4 F. Hoffmann-La Roche Ltd. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.13 Amgen Inc.
8.13.1 Company Profiles
8.13.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.13.3 Amgen Inc. Production, Value ($), Price, Gross Margin 2014-2019
8.13.4 Amgen Inc. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.14 Daiichi Sankyo Company, Limited
8.14.1 Company Profiles
8.14.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.14.3 Daiichi Sankyo Company, Limited Production, Value ($), Price, Gross Margin 2014-2019
8.14.4 Daiichi Sankyo Company, Limited Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.15 Takeda Pharmaceutical Company Limited
8.15.1 Company Profiles
8.15.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.15.3 Takeda Pharmaceutical Company Limited Production, Value ($), Price, Gross Margin 2014-2019
8.15.4 Takeda Pharmaceutical Company Limited Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.16 Sanwa Kagaku Kenkyusho Co., Ltd.
8.16.1 Company Profiles
8.16.2 Glucose-Dependent Insulinotropic Receptor Product Introduction
8.16.3 Sanwa Kagaku Kenkyusho Co., Ltd. Production, Value ($), Price, Gross Margin 2014-2019
8.16.4 Sanwa Kagaku Kenkyusho Co., Ltd. Market Share of Glucose-Dependent Insulinotropic Receptor Segmented by Region in 2018
8.17 Array BioPharma Inc.
9 Global Glucose-Dependent Insulinotropic Receptor Market Analysis and Forecast by Type and Application
9.1 Global Glucose-Dependent Insulinotropic Receptor Market Value ($) & Volume Forecast, by Type (2019-2026)
9.1.1 17-i Market Value ($) and Volume Forecast (2019-2026)
9.1.2 ARRY-981 Market Value ($) and Volume Forecast (2019-2026)
9.1.3 AS-1669058 Market Value ($) and Volume Forecast (2019-2026)
9.1.4 DS-8500 Market Value ($) and Volume Forecast (2019-2026)
9.1.5 GSK-2041706 Market Value ($) and Volume Forecast (2019-2026)
9.1.6 HD-0471042 Market Value ($) and Volume Forecast (2019-2026)
9.2 Global Glucose-Dependent Insulinotropic Receptor Market Value ($) & Volume Forecast, by Application (2019-2026)
9.2.1 Application 1 Market Value ($) and Volume Forecast (2019-2026)
9.2.2 Application 2 Market Value ($) and Volume Forecast (2019-2026)
9.2.3 Application 3 Market Value ($) and Volume Forecast (2019-2026)
9.2.4 Application 4 Market Value ($) and Volume Forecast (2019-2026)
9.2.5 Application 5 Market Value ($) and Volume Forecast (2019-2026)
10 Glucose-Dependent Insulinotropic Receptor Market Analysis and Forecast by Region
10.1 North America Market Value ($) and Consumption Forecast (2019-2026)
10.2 Europe Market Value ($) and Consumption Forecast (2019-2026)
10.3 China Market Value ($) and Consumption Forecast (2019-2026)
10.4 Japan Market Value ($) and Consumption Forecast (2019-2026)
10.5 Middle East & Africa Market Value ($) and Consumption Forecast (2019-2026)
10.6 India Market Value ($) and Consumption Forecast (2019-2026)
10.7 South America Market Value ($) and Consumption Forecast (2019-2026)
11 New Project Feasibility Analysis
11.1 Industry Barriers and New Entrants SWOT Analysis
11.2 Analysis and Suggestions on New Project Investment
12 Research Finding and Conclusion
13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Maia Subscription Portal
13.3 Research Data Source
13.4 Research Assumptions and Acronyms Used
